Please enable Javascript to get a taste of that Hopium 👼

ABBV - Financials Overview - AbbVie Inc

Financials

We've grouped the latest 4 financial reports for ABBV. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2018201920202021
Total Revenue$32.8B$33.3B$45.8B$56.2B
Cost of Revenue$7.72B$7.44B$32.5B$37.5B
Gross Margin$25.0B$25.8B$13.3B$18.7B
Research & Development$10.8B$6.79B$7.76B$8.05B
Selling, General and Administrative----
Other Operating Expense----
Total Operating Expense----
Operating Income$6.38B$13.0B$11.4B$17.9B
Interest Income$204M$275M$174M$39.0M
Interest Expense$1.35B$1.78B$2.45B$2.42B
Net Interest Incomee-$1.35B-$1.78B-$2.45B-$2.42B
Other Income Expense----
Non-recurring Items----
Other Non-operating Income-$18.0M-$3.01B-$5.61B-$2.50B
Income before Provision for income taxes$5.20B$8.43B$3.39B$13.0B
Tax Provision-$490M$544M-$1.22B$1.44B
Net Income$5.69B$7.88B$4.62B$11.5B
Effect of accounting charges----
Minority Interest----
Provision for income taxes----
Non-recurring items----
Other Items----
Discontinued Operations----
Preferred Stock Dividends----
EBIT$6.55B$10.2B$5.85B$15.4B
Balance Sheet2018201920202021
otherNonCurrentAssets----
Assets
Cash, Cash Equivalents & Short-term investments$8.06B$39.9B$8.48B$9.83B
Cash & Cash Equivalents----
Other Short-term Investments$772M-$30.0M$84.0M
Receivables----
Inventory$1.61B$1.81B$3.31B$3.13B
Other Current Assets$1.90B$2.35B$3.56B$4.99B
Total Current Assets$16.9B$49.5B$24.2B$27.9B
PPE$2.88B$2.96B$5.25B$5.11B
Non-current Marketable Securities$1.42B$93.0M$293M$277M
total non-current assets$42.4B$39.6B$126B$119B
Goodwill$15.7B$15.6B$33.1B$32.4B
Other Intangible Assets$36.9B$34.3B$116B$108B
deferred long-term asset charges----
Total Assets$59.4B$89.1B$151B$147B
Liabilities
Accounts Payable----
Current Debt$3.70B-$34.0M$14.0M
Other Current Liabilties$10.4B$10.4B$17.9B$19.8B
Total Current Liabilities$17.2B$15.6B$28.7B$35.2B
Long Term Debt$35.0B$67.2B$84.9B$76.0B
Non-Current Deferred Liabilties----
Negative Goodwill----
Other Non-Current Liabilities$1.31B$17.6B$27.6B$28.7B
total non-current liabilities$49.5B$80.6B$131B$119B
Total capital lease obligations--$21.0M$25.0M
Total Liabilities$74.2B$103B$137B$131B
Shareholder's Equity
Common Stock----
Share premium----
Preferred Stock----
Retained Earnings----
Additional Paid-in Capital----
Gains/Losses not affecting retained earnings----
Treasury Stock$24.1B$24.5B$2.26B$3.14B
Total Shareholders' Equity-$8.45B-$8.17B$13.1B$15.4B
Total Liabilities and Shareholders' Equity----
Cash Flow2018201920202021
Cash from Operating Activities
Operating Activities$13.4B$13.3B$17.6B$22.8B
Other Operating Activities----
Change(increase) in Operating Activities----
Net Income$5.69B$7.88B$4.62B$11.5B
Depreciation----
Change in Liabilities----
Change in Inventory$226M$231M$40.0M$142M
Change(increase) in Account Receivables----
Change(increase) in Receivables$591M$74.0M$929M$1.32B
Cash from Investing Activities
Investment Activities-$1.01B$596M-$37.6B-$2.34B
Other Investment Activities----
Investments----
Capital Expenditures$638M$552M$798M$787M
Cash from Financing Activities
Financing Activities-$14.4B$18.7B-$11.5B-$19.0B
Other Financing Activities----
Stock Sale and Purchase----
Dividends$5.58B$6.37B$7.72B$9.26B
Net Borrowings----
Change(increase) in Cash----
Change(increase) in Cash and Cash Equivalents-$2.01B$32.6B-$31.5B$1.30B
Change(increase) in Net Income----
Change in Exchange Rate-$39.0M$7.00M-$5.00M-$97.0M
Data source(s): Alpha Vantage